Concepedia

Xuemei Wan

XW

Statistics

Publications

21

Citations

595

H-Index

15

Active since

2015

Affiliations

State Key Laboratory of Biotherapy(Current)

Sichuan University

Yantai University

Oregon State University

Chengdu University of Traditional Chinese Medicine

Xuemei Wan is an author at State Key Laboratory of Biotherapy specializing in life sciences, pharmacology, and drug discovery.

ORCID

Publications per year

2015–2022

21

Publications

21

Coibamide A Targets Sec61 to Prevent Biogenesis of Secretory and Membrane Proteins

Dale Tranter, Anja Paatero, Shinsaku Kawaguchi et al. · ACS Chemical Biology · 2020 · 67 citations · Full text

, , +13

Coibamide A, a natural lariat depsipeptide, inhibits VEGFA/VEGFR2 expression and suppresses tumor growth in glioblastoma xenografts

Jeffrey Serrill, Xuemei Wan, Andrew M. Hau et al. · Investigational New Drugs · 2015 · 59 citations

, , +16

Puerarin induces Nrf2 as a cytoprotective mechanism to prevent cadmium-induced autophagy inhibition and NLRP3 inflammasome activation in AML12 hepatic cells

Zhao-Ming Yu, Xuemei Wan, Min Xiao et al. · Journal of Inorganic Biochemistry · 2021 · 47 citations

, , +17

Puerarin attenuates cadmium-induced hepatic lipid metabolism disorder by inhibiting oxidative stress and inflammation in mice

Xuemei Wan, Jing Chen, Min Wang et al. · Journal of Inorganic Biochemistry · 2021 · 43 citations

, , +14

Puerarin prevents cadmium-induced hepatic cell damage by suppressing apoptosis and restoring autophagic flux

Xue-Lei Zhou, Xuemei Wan, Xiaoxu Fu et al. · Biomedicine & Pharmacotherapy · 2019 · 38 citations · Full text

, , +17

1–5 of 21